Department of Medicinal Chemistry

 

Seminar Schedule

SPRING SEMESTER 2012
TUESDAYS AT 3:35 PM
7-135WDH
 

JANUARY
24 - Dr. Katherine Seley-Radtke

Flexibility. A New Paradigm for Nucleoside Drug Design
Professor, Medicinal & Bioorganic Chemistry
University of Maryland, Baltimore Co.

31 - Dr. Tomi K. Sawyer’s seminar has been moved to May 1, 2012

FEBRUARY
7 - Margaret E. Olson

Synthetic Carbohydrate-Based Vaccines: Exploiting the Tumor Associated Antigen sTn for Cancer Therapeutic Development
Graduate Student - Medicinal Chemistry
University of Minnesota

14 - Dr. Silvia Balbo
Development of a High-resolution Mass Spectrometry Method for the Observation and Characterization of Unknown Adducts in Human DNA
Research Associate
Masonic Cancer Ctr.-University of Minnesota

21 - Dr. Alexander Doemling
Instant Discovery of Protein-Protein Interaction Antagonists Using Anchor Query
Professor
Department of Pharmaceutical Sciences
University of Pittsburgh

28 - Jingling Shen
Theranostic Nanoparticles Modified with Tumor Targeting Ligands for Delivery of siRNA for Cancer Therapy
Graduate Student – Medicinal Chemistry
University of Minnesota 

MARCH
6 - Dr. Caren L. Meyers

Intracellular Delivery of Polyphosphonates: The Chemistry and Biology of Bisphosphonamidate Prodrugs
Department of Pharmacology & Molecular Sciences
Johns Hopkins University School of Medicine

11-17 No Seminar – Spring Break Week

20 - Dr. Steven Rokita
Reversible Alkylation of DNA by Quinone Methide Intermediates
Professor of Chemistry & Biochemistry
University of Maryland

25 – 29 No Seminar - ACS Meeting in San Diego CA 

APRIL
3 - Dr. Gabriel Fenteany

Chemical Approaches to Understanding and Controlling Cell Migration
Associate Professor
Department of Chemistry
University of Connecticut

17 - Bo Zhou
Tethering – A Novel Tool for Fragment-Based Drug Discovery
Graduate Student- Medicinal Chemistry
University

MAY
1 - Dr. Tomi K. Sawyer

Stapled Helical Peptides: Chemical Biology and Drug Design
Chief Scientific Officer, SVP Discovery & Technologies
Aileron Therapeutics